Virtual Pharmaship’s Post

 Researchers found the endocannabinoid 2-arachydonoyl-glycerol (2-AG) repairs both synaptic plasticity and memory in those who consumed excessive alcohol. 2-AG is a molecule produced by our complex Endocannabinoid system (ECS) and enhanced by the intake of plant constituent and other natural means. It's known as an eicosanoid - these play a complex and important role in various bodily processes including immunity and inflammation. https://lnkd.in/gWTy8kVP

This helps explain why #CBD “hangover” drinks are so effective.

Positive top-line results from the ongoing Phase 2a study evaluating our #nanoparticle as a potential treatment for #PrimaryBiliaryCholangitis (PBC).

I am happy to share with you our new publication where we compare two methods for warfarin dosing and their effect on anticoagulation outcomes. (The ClinFix study) https://lnkd.in/dbMWsy_3

Security of the Day: Structured Note linked to Editas Medicine Inc ISIN: US05600MF907 SQX-Evaluated Price: $6.850 Superbugs beware. A powerful new antibiotic is in town. While modern medicine is truly remarkable, it faces a difficult challenge: superbugs. These bacteria have developed immunity against modern antibiotics, rendering them untreatable. Until now. Recently, scientists have discovered a new chemical compound, known as Cresomycin, that is capable of breaking through superbugs’ drug-resistant shields. This discovery marks a promising step forward for medicine, leading us into a future safe from malicious superbugs. In honor of this new medical chemical, today’s Security of the Day is a structured note linked to Editas Medicine Inc! Did you know that SQX, Securities Quote Xchange LLC provides prices for the universe of structured notes every day? #derivatives #data #finance

Live case highlights from the 10th EUVIC Live procedure of bilateral varicose veins under the expertise of Dr. Ravul Jindal, Dr. Erika Mendoza and Dr. Wassila Taha. Showcasing the reflux of veins in real time and much more. Get an insight of advanced techniques and clinical excellence. #euvic2024 #drravuljindal #vericoseveins #vericoseveintreatment #livecase

New data from the phase 3 ELATIVE trial demonstrate the efficacy of elafibranor (Ipsen) in managing PBC progression after 78 weeks of treatment, with results additionally showing its potential to improve itch-related quality of life. Learn more: https://lnkd.in/eFcdBARs #Hepatology

The Quidel TriageTrue® High Sensitivity Troponin I Test, CE-marked in late 2018, demonstrates clinical performance akin to top central lab systems. Its assay-specific cutoffs for ESC 0–1 hour algorithm are validated and published in the ESC 2020 guidelines. Dr. Annemieke Dohmann discusses the benefits of the Triage MeterPro and TriageTrue® test in the clinical setting. QuidelOrtho #troponin #pointofcare #poct #clinicaldiagnostics #medicallaboratory #clinicallaboratory https://lnkd.in/ehKxtnv7

For pts with #myelofibrosis who have intolerance or lack of response to #ruxolitinib, the #JAK2inhibitor #fedratinib can successfully reduce spleen size, according to the #FREEDOM2 international phase III trial #Heme https://lnkd.in/eC27qfVp

Please see below!